CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 137 filers reported holding ANAPTYSBIO INC in Q4 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$2,568,478
-9.6%
143,011
+2.4%
0.00%0.0%
Q2 2023$2,839,708
-12.6%
139,612
-6.5%
0.00%0.0%
Q1 2023$3,250,639
-29.5%
149,386
+0.4%
0.00%0.0%
Q4 2022$4,612,273
+24.3%
148,831
+2.3%
0.00%0.0%
Q3 2022$3,712,000
+28.4%
145,488
+2.2%
0.00%0.0%
Q2 2022$2,891,000
-17.8%
142,401
+0.2%
0.00%0.0%
Q1 2022$3,517,000
-25.8%
142,131
+4.3%
0.00%0.0%
Q4 2021$4,737,000
+28.8%
136,312
+0.5%
0.00%0.0%
Q3 2021$3,679,000
-0.7%
135,638
-5.0%
0.00%0.0%
Q2 2021$3,704,000
+26.6%
142,827
+5.2%
0.00%0.0%
Q1 2021$2,926,000
-4.4%
135,732
-4.7%
0.00%0.0%
Q4 2020$3,062,000
+46.9%
142,389
+0.7%
0.00%0.0%
Q3 2020$2,085,000
-40.0%
141,333
-9.1%
0.00%
-50.0%
Q2 2020$3,474,000
+61.4%
155,472
+2.0%
0.00%
+100.0%
Q1 2020$2,153,000
-11.2%
152,361
+2.1%
0.00%0.0%
Q4 2019$2,425,000
-52.7%
149,185
+1.8%
0.00%
-66.7%
Q3 2019$5,129,000
-34.7%
146,568
+5.3%
0.00%
-40.0%
Q2 2019$7,852,000
-16.1%
139,156
+8.7%
0.01%
-16.7%
Q1 2019$9,354,000
+19.0%
128,048
+3.9%
0.01%0.0%
Q4 2018$7,863,000
-28.3%
123,260
+12.1%
0.01%
-14.3%
Q3 2018$10,974,000
+83.1%
109,988
+30.4%
0.01%
+75.0%
Q2 2018$5,992,000
-27.4%
84,342
+6.4%
0.00%
-33.3%
Q1 2018$8,251,000
+9.3%
79,275
+5.8%
0.01%0.0%
Q4 2017$7,548,000
+557.5%
74,940
+128.2%
0.01%
+500.0%
Q3 2017$1,148,000
+146.9%
32,846
+69.3%
0.00%
Q2 2017$465,000
+67.3%
19,402
+94.3%
0.00%
Q1 2017$278,0009,9880.00%
Other shareholders
ANAPTYSBIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,628,678$65,033,00013.01%
EcoR1 Capital, LLC 7,521,024$186,070,0005.82%
GREAT POINT PARTNERS LLC 700,000$17,318,0004.18%
Frazier Life Sciences Management, L.P. 899,700$22,259,0001.90%
Boxer Capital, LLC 1,300,000$32,162,0001.65%
Logos Global Management LP 300,000$7,422,0000.96%
Deep Track Capital, LP 558,782$13,824,0000.89%
Palo Alto Investors LP 431,024$10,664,0000.82%
TCG Crossover Management, LLC 58,515$1,448,0000.58%
Rock Springs Capital Management LP 563,300$13,936,0000.35%
View complete list of ANAPTYSBIO INC shareholders